| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |